Correlation Between Fate Therapeutics and RAPT Therapeutics
Can any of the company-specific risk be diversified away by investing in both Fate Therapeutics and RAPT Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Fate Therapeutics and RAPT Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Fate Therapeutics and RAPT Therapeutics, you can compare the effects of market volatilities on Fate Therapeutics and RAPT Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Fate Therapeutics with a short position of RAPT Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Fate Therapeutics and RAPT Therapeutics.
Diversification Opportunities for Fate Therapeutics and RAPT Therapeutics
0.51 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Fate and RAPT is 0.51. Overlapping area represents the amount of risk that can be diversified away by holding Fate Therapeutics and RAPT Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on RAPT Therapeutics and Fate Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Fate Therapeutics are associated (or correlated) with RAPT Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of RAPT Therapeutics has no effect on the direction of Fate Therapeutics i.e., Fate Therapeutics and RAPT Therapeutics go up and down completely randomly.
Pair Corralation between Fate Therapeutics and RAPT Therapeutics
Given the investment horizon of 90 days Fate Therapeutics is expected to under-perform the RAPT Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Fate Therapeutics is 1.32 times less risky than RAPT Therapeutics. The stock trades about -0.02 of its potential returns per unit of risk. The RAPT Therapeutics is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest 1,861 in RAPT Therapeutics on September 24, 2024 and sell it today you would lose (1,693) from holding RAPT Therapeutics or give up 90.97% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Fate Therapeutics vs. RAPT Therapeutics
Performance |
Timeline |
Fate Therapeutics |
RAPT Therapeutics |
Fate Therapeutics and RAPT Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Fate Therapeutics and RAPT Therapeutics
The main advantage of trading using opposite Fate Therapeutics and RAPT Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Fate Therapeutics position performs unexpectedly, RAPT Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in RAPT Therapeutics will offset losses from the drop in RAPT Therapeutics' long position.Fate Therapeutics vs. Atara Biotherapeutics | Fate Therapeutics vs. Sana Biotechnology | Fate Therapeutics vs. Caribou Biosciences | Fate Therapeutics vs. Arcus Biosciences |
RAPT Therapeutics vs. Fate Therapeutics | RAPT Therapeutics vs. Sana Biotechnology | RAPT Therapeutics vs. Caribou Biosciences | RAPT Therapeutics vs. Arcus Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |